is there a shortage of compounded semaglutide The market for GLP-1 drugs remained robust despite the end (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) shortages, with many facilities adding ingredients like B vitamins and some operating with Counterfeit Ozempic Crackdown: Drugmakers Threaten

Appl Environ Microbiol 2007

Therefore, strong CYP3A4/5 inhibitors and inducers will alter the pharmacokinetics of saxagliptin and its active metabolite [see DRUG INTERACTIONS (7)]

Source: Novo Nordisk For example, Novo Nordisks own estimates show there are almost 430 million people with a body mass index above 35

The FDA is involved at many levels and is undergirded by a large pool of volunteers that is in the millions allowing for more rapid recruitment and trial completion

These medications are only available to people with a body mass index (BMI) of 27 or over with at least one weight-related health condition or those with a BMI of 30 or over

Explore More Premium Products Browse our complete collection of premium products and research compounds